Abstract
Of the ~80 putative toxin‐antitoxin (TA) modules encoded by the bacterial pathogen Mycobacterium tuberculosis (Mtb), three contain antitoxins essential for bacterial viability. One of these, Rv0060 (DNA ADP‐ribosyl glycohydrolase, DarGMtb), functions along with its cognate toxin Rv0059 (DNA ADP‐ribosyl transferase, DarTMtb), to mediate reversible DNA ADP‐ribosylation (Jankevicius et al., 2016). We demonstrate that DarTMtb‐DarGMtb form a functional TA pair and essentiality of darGMtb is dependent on the presence of darTMtb, but simultaneous deletion of both darTMtb‐darGMtb does not alter viability of Mtb in vitro or in mice. The antitoxin, DarGMtb, forms a cytosolic complex with DNA‐repair proteins that assembles independently of either DarTMtb or interaction with DNA. Depletion of DarGMtb alone is bactericidal, a phenotype that is rescued by expression of an orthologous antitoxin, DarGTaq, from Thermus aquaticus. Partial depletion of DarGMtb triggers a DNA‐damage response and sensitizes Mtb to drugs targeting DNA metabolism and respiration. Induction of the DNA‐damage response is essential for Mtb to survive partial DarGMtb‐depletion and leads to a hypermutable phenotype.
Keywords: DNA damage, Mycobacterium tuberculosis, toxin‐antitoxin systems
DarT and DarG form a toxin‐antitoxin pair in M. tuberculosis. In the absence of DarG, the toxin ADP‐ribosylates DNA leading to cell death. In the presence of DarG, DarG binds to and neutralizes the toxin, and plausibly also recruits DNA repair machinery to remove the ADP‐ribosyl moiety and repair the DNA.

1. INTRODUCTION
Toxin‐antitoxin (TA) systems are ubiquitously present in prokaryotic genomes and consist of a toxic protein that inhibits an essential cellular process and a counteracting antitoxin that binds to and neutralizes the toxin (Yamaguchi et al., 2011). TA systems were originally discovered due to their ability to prevent plasmid loss by post‐segregational killing (Ogura and Hiraga, 1983; Gerdes et al., 1986). They have subsequently been implicated in various cellular pathways including phage defense, genome stabilization, and bacterial persistence (Szekeres et al., 2007; Gerdes and Maisonneuve, 2012; Harms et al., 2018).
The phyletic distribution of TA modules indicates that Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, harbors an expanded repertoire of 79 putative TA loci (Pandey and Gerdes, 2005; Sala et al., 2014; Slayden et al., 2018). Individual deletions of many of these TA loci exhibit few, if any phenotypic defects, likely due to functional redundancy (Singh et al., 2010; Tiwari et al., 2015). However, 3 of the 79 TA modules in Mtb harbor antitoxins that are essential for viability of the organism, namely Rv0060, Rv1044, and Rv1990c (DeJesus et al., 2017). Rv1044 is uncharacterized, and Rv1990c was recently identified as MbcA, an antitoxin that neutralizes a NAD+ phosphorylase toxin, MbcT (Freire et al., 2019). Rv0060 (DarGMtb), and its cognate toxin, Rv0059 (DarTMtb), are the focus of this study.
Within mycobacteria, the darT‐darG locus is found only in species belonging to the Mtb complex (Kanehisa and Goto, 2000). However, orthologous genes have been identified in the extremophile Thermus aquaticus (Taq) and in enteropathogenic E. coli (EPEC) (Jankevicius et al., 2016; Lawaree et al., 2020). In vitro experiments established that DarTTaq, DarTEc, and DarTMtb can ADP‐ribosylate single stranded DNA at thymidine residues (Jankevicius et al., 2016; Lawaree et al., 2020). In both E. coli and T. aquaticus, the antitoxin, DarG, physically interacts with DarT, leading to toxin neutralization. In addition, DarGTaq, DarGEc, and DarGMtb can enzymatically reverse the action of their cognate toxins by removal of the ADP‐ribose moiety (Jankevicius et al., 2016; Lawaree et al., 2020). Taken together, biochemical characterization demonstrates that DarTMtb‐DarGMtb mediate reversible ADP‐ribosylation of DNA (Jankevicius et al., 2016).
While the biological roles of DarTMtb‐DarGMtb remain unknown, in vivo studies performed on the orthologous E. coli DarTG system find that ADP‐ribosylation by DarTEc halts DNA replication. The resulting DNA lesions are repaired by two DNA‐repair pathways: RecF‐mediated homologous recombination and nucleotide excision repair (Lawaree et al., 2020). In this study, we characterize the Mtb orthologs of the DarTG system by delineating the cellular processes affected by genetic perturbation of the darTMtb‐darGMtb locus.
2. RESULTS
2.1. DarTMtb and DarGMtb form a toxin‐antitoxin pair that is dispensable for growth in vitro, growth in mice, persistence in mice, and resistance to various stresses
Tn‐seq studies predicted that darGMtb is essential for growth in Mtb (DeJesus et al., 2017). We asked if the essentiality of darGMtb was dependent on the presence of darTMtb. We attempted to generate a deletion strain of both darT and darG in Mtb by replacement of the native locus with a hygromycin resistance cassette. We failed to obtain mutant colonies, suggesting that darGMtb could be essential even when darTMtb was absent (Figure 1a, top row). To test this, we used an alternate strategy to obtain ΔdarTMtb‐darGMtb. First, we generated a strain that contained a second copy of darGMtb on an attL5‐integrating plasmid with a streptomycin resistance cassette (Figure 1a, middle row). In this merodiploid we then successfully replaced the native darTMtb‐darGMtb locus with a hygromycin resistance cassette (Figure 1a, bottom row). Resident plasmids at the attL5 site can be efficiently switched with another attL5‐integrating plasmid containing a different antibiotic‐resistance cassette (Pashley and Parish, 2003). Hence, we transformed the ΔdarTMtb‐darGMtb::darGMtb strain with an attL5‐integrating plasmid conferring zeocin‐resistance but not expressing any Mtb gene. We successfully obtained zeocin‐resistant colonies (Figure 1a, bottom row). We confirmed the resulting ΔdarTMtb‐darGMtb mutant by Southern blotting (Figure S1). ΔdarTMtb‐darGMtb exhibited no growth defect in standard 7H9 media (Figure 1b) and showed growth and survival comparable to WT following infection of C57B/6 mice (Figure 1c–1d). The mutant also failed to show a phenotype when subjected to various stressors including the antibiotics isoniazid, rifampicin, ciprofloxacin, levofloxacin, the anticancer drug mitomycin C (used as a DNA damaging agent; Iyer and Szybalski, 1963), starvation, nitric oxide, and H2O2 (Figure S2).
Figure 1.

Generation and growth of ΔdarTMtb‐darGMtb in vitro and in vivo. (a) Schematic depicting generation of ΔdarTMtb‐darGMtb. (b) Growth of WT and ΔdarTMtb‐darGMtb in 7H9 media as measured by optical density. (c and d) Quantification of bacterial loads in (c) lungs and (d) spleens of C56BL/6 mice infected with WT or ΔdarTMtb‐darGMtb Mtb. Data are mean ± SD of four mice per group
These findings establish that the essentiality of darGMtb is dependent on the presence of darTMtb and confirm that the two form a toxin‐antitoxin pair. Toxicity from residual DarTMtb protein in the cytoplasm likely explains our failure to obtain the ΔdarTMtb ‐ darGMtb mutant by direct replacement in the WT strain.
2.2. DarGMtb interacts with DarTMtb and with proteins involved in DNA replication and repair
It is common for antitoxin proteins to inhibit their cognate toxins by direct protein–protein interactions (Yamaguchi et al., 2011). Hence, we expressed and immunoprecipitated a FLAG‐tagged version of DarGMtb in WT Mtb and identified interacting proteins by mass spectrometry. Indeed, we found that DarGMtb bound to DarTMtb (Figure 2a, Table 1). In addition, 9 of the top 20 hits were proteins related to DNA metabolism. Specifically, we identified interactions between DarGMtb and members of the mycobacterial replisome including the replicative polymerases (DnaE1, PolA), helicase (DnaB), and primase (DnaG). DNA‐repair‐associated proteins such as RecA, RecB, RecF, Lhr, and AlkA were also part of the DarGMtb interactome (Figure 2a, Table 1, and S1). We then tested if the association of DarGMtb was dependent on an interaction with DNA or the ribosylation of DNA or proteins (Figure 2b). For example, co‐precipitation of DarGMtb with any DNA‐binding protein could potentially be explained by the presence of complexes containing DNA bound independently to DarGMtb and to resident DNA‐binding proteins (Figure 2b, Model I). To test this, we repeated the pull‐down on DNase‐treated lysates. We did not find a substantial difference in the protein‐binding profile of DarGMtb with or without DNase treatment (Table 1), thus, ruling out Model I. Next, we conjectured that DarGMtb might recruit DNA‐repair proteins on recognition and binding to an ADP‐ribosylated base (Figure 2b, Model II). Our results could also be explained by ADP‐ribosylation of the interacting proteins themselves (Figure 2b, Model III). We tested these possibilities by repeating the pull‐down in a strain lacking DarTMtb, and therefore, presumably lacking ADP‐ribosylation. Interactions between DarGMtb and DNA metabolism proteins persisted even in the absence of DarTMtb. In short, DarGMtb bound to DNA metabolism‐related proteins in a DarTMtb‐independent manner.
Figure 2.

DarGMtb interacts with DarTMtb and with proteins involved in DNA replication and repair. (a) Network map of selected interacting partners of DarGMtb. DarTMtb is marked in orange. (b) Schematics displaying possible modes of interaction between DarGMtb (blue), DNA‐binding proteins (colored circles), and DNA. ADP‐ribosylation is represented by a brown line. The most plausible model is boxed. (c) Raw read counts from chromatin immunoprecipitation experiments for DosR‐FLAG, FLAG‐control, and DarGMtb‐FLAG plotted against the Mtb H37Rv genome coordinate. Peaks within selected genes are annotated. Data are representative of three independent replicates
Table 1.
DarGMtb interacts with proteins involved in DNA replication and repair
| Rank | Rv | Gene | Description | iP: DarGMtb in WT | iP: DarGMtb in WT + DNaseI | iP: DarGMtb in DKO |
|---|---|---|---|---|---|---|
| 1 | Rv3296 | lhr | Probable ATP‐dependent helicase Lhr | 22.75 | 18.5 | 18 |
| 2 | Rv1547 | dnaE1 | Probable DNA polymerase III DnaE1 | 18.75 | 15 | 23 |
| 3 | Rv0058 | dnaB | Probable replicative DNA helicase DnaB | 15.5 | 7.5 | 6 |
| 4 | Rv2343c | dnaG | Probable DNA primase DnaG | 20.25 | 15.5 | 9.5 |
| 7 | Rv0059 | darT | DNA ADP‐ribosyl transferase DarT | 24 | 31 | 0.9 |
| 10 | Rv1629 | polA | Probable DNA polymerase I PolA | 12 | 14 | 9.5 |
| 12 | Rv0630c | recB | Probable exonuclease V (beta chain) RecB | 11.25 | 5 | 5 |
| 16 | Rv3051c | nrdE | Ribonucleoside‐diphosphate reductase NrdE | 14.5 | 18.5 | 30 |
| 18 | Rv2737c | recA | RecA protein (recombinase A) | 33.5 | 27.5 | 33.5 |
| 22 | Rv3208 | rv3208 | Probable transcriptional regulatory protein (probably TetR‐family) | 8.5 | 11 | 9 |
| 30 | Rv1701 | rv1701 | Probable integrase/recombinase | 16.25 | 9 | 6.5 |
| 34 | Rv1317c | alkA | Probable bifunctional regulatory protein and DNA‐repair enzyme AlkA | 7.25 | 5.5 | 4.5 |
| 47 | Rv1267c | embR | Probable transcriptional regulatory protein EmbR | 15.25 | 17.5 | 12.5 |
| 57 | Rv0823c | rv0823c | Possible transcriptional regulatory protein | 7.75 | 8 | 5 |
| 61 | Rv0003 | recF | DNA replication and repair protein RecF | 9.25 | 8 | 5.5 |
| 62 | Rv2258c | rv2258c | Possible transcriptional regulatory protein | 8.75 | 10.5 | 10.5 |
| 65 | Rv3644c | rv3644c | Possible DNA polymerase | 10.25 | 9 | 5.5 |
| 66 | Rv1446c | opcA | Putative OXPP cycle protein OpcA | 12 | 7 | 7 |
| 67 | Rv3164c | moxR3 | Probable methanol dehydrogenase transcriptional regulatory protein MoxR3 | 8 | 5.5 | 4 |
| 90 | Rv2718c | nrdR | Probable transcriptional regulatory protein NrdR | 8.25 | 8.5 | 9 |
| 91 | Rv3246c | mtrA | Two component sensory transduction transcriptional regulatory protein MtrA | 9 | 9 | 13 |
Rank, names, and average total spectrum counts of DNA metabolism‐related proteins identified to interact with DarGMtb are displayed. DarGMtb‐FLAG was immunoprecipitated (iP) from whole‐cell lysates of WT or ΔdarTMtb‐darGMtb (DKO) Mtb strains transformed with plasmids encoding DarGMtb‐FLAG under a constitutive promoter. “DarGMtb in WT + DNaseI” represents data from WT lysates treated with DNaseI post iP. Interacting proteins were identified by mass spectrometry. Data were calculated from four biological replicates (iP: DarGMtb in WT) or biological duplicates (iP: DarGMtb in WT + DNaseI, iP: DarGMtb in DKO). Biological duplicates of WT Mtb and an experiment with WT Mtb overexpressing a FLAG tag were used as controls. Nonspecific binding peptides were removed from the results by setting the filter of “Total Spectrum Count” of each replicate to “≤4” in the control samples and “≥5” in “DarGMtb in WT” samples. Hits were ranked in descending order based on the ratio of average total spectrum count of “DarGMtb in WT” versus controls, with the corresponding rank indicated in the “Rank” column. Unfiltered raw counts are available in the Supporting Information (Table S1).
Finally, we examined if DarGMtb either co‐localized with (Figure 2b, Model IV) or directly bound to DNA (Figure 2b, Model V). We performed microscopy using DarGMtb‐mCherry and SYTO13‐labeled DNA (Figure S3). We observed variable localization of DarGMtb‐mCherry. Specifically, 44% of bacteria contained DarGMtb‐mCherry foci which did not overlap with SYTO13‐labeled DNA. The remaining bacteria contained diffuse mCherry signals (Figure S3). Since these results were inconclusive, we performed chromatin immunoprecipitation (ChIP‐seq) using an anti‐FLAG antibody on lysates of WT Mtb expressing DarGMtb‐FLAG, DosR‐FLAG (positive control), or the FLAG tag alone (negative control). Compared to the FLAG tag control, there was little or no enrichment of read counts in the DarGMtb‐FLAG ChIP (Figure 2c; no significant differentially bound sites detected using DiffBind (Stark and Brown, 2011)), with the exception of a peak mapping to darGMtb. Since these read counts are not normalized to the ChIP input, this peak is likely an artifact originating from the multicopy episomal plasmid encoding DarGMtb‐FLAG. In contrast, enriched peaks of known DosR targets, hspX and rv2628, were detected in the DosR ChIP (Figure 2c). While we cannot rule out short‐lived and/or nonsequence‐specific interactions with DNA that would be undetectable by ChIP‐seq, these data demonstrate that DarGMtb likely forms a cytosolic complex with DNA‐repair proteins that assembles independently of an interaction with DNA (Figure 2b, Model VI).
2.3. DarGMtb‐depletion triggers cell death which is prevented by its T. aquaticus ortholog
Next, we sought to understand the downstream effects of DarTMtb expression. We were unable to overexpress DarTMtb in Mtb, since its toxicity in E. coli precluded our attempts to clone the gene, similar to previous attempts (Jankevicius et al., 2016). Instead, we generated an anhydrotetracycline (ATC)‐controlled knockdown strain of darGMtb with the expectation that DarGMtb‐depletion would phenocopy overexpression of darTMtb. Briefly, we achieved proteolytic control of native DarGMtb by its fusion to a carboxy‐terminal DAS‐tag. DAS‐tagged proteins are targeted to the ClpP protease by adapter protein SspB, which was expressed under the control of the reverse Tet repressor (Kim et al., 2011). In the resulting darGMtb‐TetON strain, removal of ATC led to a decrease in the expression of DarGMtb which was accompanied by cell death (Figure 3a‐b). The toxicity associated with DarGMtb‐depletion was fully rescued by constitutive expression of either DarGMtb, or its ortholog from T. aquaticus, DarGTaq (Figure 3c). Mutation of K80 in DarGTaq abrogates the protein's de‐ADP‐ribosylation activity (Jankevicius et al., 2016). In concordance with this, a K80A mutant of DarGTaq failed to rescue ATC‐dependent growth of darGMtb‐TetON (Figure 3c). Finally, we examined the consequences of overexpressing DarTTaq in Mtb. We transformed ΔdarTMtb‐darGMtb with a plasmid encoding darTTaq under an ATC‐inducible promoter. The resulting strain was unable to grow when exposed to ATC, a phenotype that was rescued by constitutive expression of DarGMtb (Figure 3d). Overall, these data establish that the DarTMtb‐DarGMtb toxin‐antitoxin system is cross‐complemented by DarTTaq‐DarGTaq, thus signifying functional conservation.
Figure 3.

DarGMtb‐depletion triggers cell death which is prevented by its T. aquaticus ortholog. (a) Immunoblot of protein extracts from darGMtb‐TetON grown with and without ATC. Blot was probed with DarGMtb‐specific and DlaT‐specific (loading control) antisera (b) Growth of darGMtb‐TetON quantified by CFU in 7H9 medium with or without ATC. (c) 7H10 agar plates cultured with darGMtb‐TetON transformed with empty plasmid or plasmids encoding darGMtb WT, darGTaq WT, or darGTaq mutant expressed from constitutive promoters. The disk in the center of the plate contains 100 ng of ATC; the concentration of ATC decreases from the center to the periphery of the plate. (d) 7H10 agar plates cultured with ΔdarTMtb‐darGMtb containing a plasmid encoding darTTaq from an ATC‐inducible promoter transformed with or without a plasmid encoding darGMtb from a constitutive promoter. The disk in the center of the plate contains 800 ng of ATC; the concentration of ATC decreases from the center to the periphery of the plate. Data in (b) are means ± SD from three independent experiments. Data in (c‐d) are representative of at least two independent experiments
Since we were unable to detect binding of DarGMtb to DNA under baseline conditions (Figure 2c), we asked if DarGMtb bound DNA upon induction of ADP‐ribosylation in the cell. We tested this by performing chromatin immunoprecipitation of FLAG‐tagged DarGMtb from cells expressing ATC‐inducible DarTTaq (Figure 3d). We found no differences in mapped reads between cells grown with and without ATC (Figure S4; no significant differentially bound sites detected using DiffBind (Stark and Brown, 2011)), indicating that DarGMtb does not form stable and consistent interactions with DNA even on overexpression of an active DNA ADP‐ribosylase.
2.4. DarGMtb‐depletion sensitizes Mtb to drugs targeting DNA metabolism and respiration
Next, we tested if targeting DarGMtb sensitizes Mtb to a panel of antibacterial compounds. We measured the MIC of each drug to darGMtb‐TetON while simultaneously varying the extent of DarGMtb knockdown. DarGMtb‐depleted (ATC‐low) Mtb were most susceptible to drugs targeting respiration (bedaquiline), gyrase (ciprofloxacin, levofloxacin), transcription (rifampicin, rifabutin), and causing DNA damage (mitomycin C, netropsin) (Figure 4b,c). In contrast, MICs of drugs inhibiting translation, and cell wall synthesis were largely unaffected by knockdown of DarGMtb (Figure 4a,c). These data suggest that depletion of DarGMtb pre‐sensitizes the cells to DNA‐damage inducing drugs. Thus, inhibition of DarGMtb likely perturbs cellular pathways involved in respiration and DNA metabolism.
Figure 4.

DarGMtb‐depletion sensitizes Mtb to drugs targeting DNA metabolism and respiration. (a and b) Susceptibility of darGMtb‐TetON to (a) chloramphenicol or (b) rifampicin. darGMtb‐TetON was cultured in 7H9 medium without ATC for 6 days to decrease DarGMtb expression before incubating with indicated concentrations of ATC and drug. Growth was measured after 14 days using optical density and normalized to that in the corresponding ATC concentration without drug treatment. (c) Heat‐map representation of the MIC50 shift of darGMtb‐TetON to antimicrobial compounds. Experiments were performed as in (a) and (b). Values within each cell are the MIC50 for darGMtb‐TetON grown in high ATC (H; 150 ng/ml) and low ATC (L; concentration of ATC that led to a ~70% growth defect in the absence of drug), normalized to high ATC. Data in (a–b) are representative of three independent experiments. Data in (c) are means calculated from three independent experiments. Symbols on the right indicate results from one‐sided t test (ns indicates non‐significant, * indicates p value ≤ 0.05, ** indicates p value ≤ 0.01, *** indicates p value ≤ .001)
2.5. DarGMtb‐depletion induces the DNA‐damage response resulting in increased mutability
To further explore the consequences of DarGMtb‐depletion, we used transposon mutagenesis followed by high‐throughput sequencing (Tn‐seq) in the darGMtb‐TetON strain. We generated transposon mutant libraries in Mtb in DarGMtb‐depleted (ATC‐low) and DarGMtb‐replete (ATC‐high) conditions. We expressed differences as the log2 fold change (log2FC) of the mutant frequency between libraries exposed to ATC‐low and ATC‐high conditions. Mutants underrepresented in the ATC‐low condition show a negative log2FC and correspond to aggravating genetic interactions with darGMtb (Figure 5a, left). In contrast, mutants with a positive log2FC are overrepresented in the ATC‐low condition and correspond to alleviating genetic interactions with darGMtb (Figure 5a, right).
Figure 5.

DarGMtb‐depletion induces the DNA‐damage response resulting in increased mutability. (a) Volcano plot representing Tn‐seq data from darGMtb‐TetON grown on 7H10 agar with low or high ATC. Tn‐seq log2FC (low ATC/high ATC) and false discovery rate‐adjusted p values (q‐values, q‐val) are plotted for each genetic locus. Loci with a q‐val ≤ 0.05 and a log2FC ≤ −1 are colored green. Loci with a q‐val ≤ 0.05 and a log2FC ≥ 1 are colored red. Selected mutants are annotated (b) Volcano plot representing RNA‐seq data from darGMtb‐TetON grown in 7H9 medium with low or high ATC. Gene expression log2FC (low ATC/high ATC) and false discovery rate‐adjusted p values (q‐values, q‐val) are plotted for each gene. Color coding is identical that in to (b) (c) darGMtb‐TetON was grown in 7H9 medium with or without ATC for 18 days before plating on 7H10 agar + ATC and with or without rifampicin (1 μg/ml). Plotted are the ratios of CFU in + rifampicin to ‐rifampicin conditions. Data from (a–c) are derived from three independent experiments
Aggravating genetic interactions were identified between darGMtb and several genes involved in DNA repair including the master DNA‐damage responsive transcriptional activators (pafBC), members of the SOS DNA‐damage response pathway (recA and recO), and the helicase involved in nucleotide excision repair (uvrD1) (Figure 5a, Table S2) (Fudrini Olivencia et al., 2017; Singh, 2017; Muller et al., 2018). Importantly, disruption of darTMtb resulted in increased survival of the DarGMtb‐depleted strain (Figure 5a, Table S2). In addition, mma4 and fecB exhibited alleviating genetic interactions with darGMtb (Figure 5a, Table S2). Mma4, methoxy mycolic acid synthase 4, is a methyl transferase that modifies cell wall mycolic acids (Yuan and Barry, 1996). FecB is annotated as a putative iron dicitrate‐binding lipoprotein, and is a determinant of the intrinsic resistance of Mtb to antibiotics (Xu et al., 2017). We reasoned that these mutants were favored due to their increased cell wall permeability which allowed greater uptake of ATC in the cell, and consequently, higher expression of DarGMtb (Dubnau et al., 2000; Xu et al., 2017).
We also sought to elucidate the transcriptomic changes associated with DarGMtb knockdown. In agreement with the Tn‐seq data, we found that targeting DarGMtb resulted in a strong induction of genes involved in DNA metabolism (Figure 5b, Table S3). Specifically, we observed a 17‐fold upregulation of dnaE2, a DNA‐damage‐induced error‐prone translesion polymerase (Boshoff et al., 2003). Expression of this gene is associated with an increased mutation frequency and consequently, an increased rate of drug resistance (Boshoff et al., 2003). Therefore, we evaluated if targeting DarGMtb altered the mutation frequency of Mtb. We cultured darGMtb‐TetON in 7H9 media either with (DarGMtb‐replete) or without (DarGMtb‐depleted) ATC before plating on ATC‐containing agar plates with rifampicin. We measured the frequency of rifampicin‐resistant Mtb as a proxy for the mutability of darGMtb‐TetON. Indeed, we found that knockdown of DarGMtb favored the emergence of rifampicin‐resistant Mtb (Figure 5c). Taken together, these results not only demonstrate that depletion of DarGMtb induces a DNA‐damage response that decreases viability, but also increases mutability.
3. DISCUSSION
DarGMtb is one of three putative antitoxins encoded in the Mtb genome that is essential for viability (DeJesus et al., 2017). Here, we demonstrate that DarTMtb‐DarGMtb indeed form a functional toxin‐antitoxin system. Removal of DarGMtb causes cell death, a phenotype that is rescued by simultaneous deletion of DarTMtb (Figure 1a, 3b). The mechanism of action of DarTMtb‐DarGMtb is functionally conserved between Mtb and Taq, as evidenced by cross‐complementation experiments (Figure 3c–d). Further, DarTMtb‐DarGMtb physically interact within the cell (Figure 2a, Table 1). However, the role of the DarTMtb‐DarGMtb system in the physiology of Mtb remains unknown, as evidenced by the lack of phenotype of the ΔdarTMtb‐darGMtb mutant in a number of physiologically relevant stress conditions (Figure 1b–d, S2). While we cannot discount the possibility of a functionally redundant TA system, the essentiality of DarGMtb and the uniqueness of DNA ADP‐ribosylation argues against this hypothesis. It has been suggested that some TA systems might primarily function to preserve genome integrity (Szekeres et al., 2007; Ramage et al., 2009), which could be the case for DarTMtb‐DarGMtb. Finally, it is possible that the DarTMtb‐DarGMtb TA system plays a role under conditions that are yet untested.
We find that induction of the DNA‐damage response is essential for Mtb to survive DarGMtb‐depletion (Figures 4, 5). Our data are in concordance with observations from EPEC showing that DarT‐mediated toxicity is aggravated by disruption of the RecFOR‐homologous recombination and nucleotide excision repair pathways (Lawaree et al., 2020). Together, these observations support the claim that DarTMtb primarily exerts its toxicity by ADP‐ribosylation of DNA (Jankevicius et al., 2016). In addition, DarGMtb forms cytosolic complexes with several proteins involved in DNA repair, either in a direct or indirect manner (Figure 2a–b, Table 1). This implies that the complex of DarGMtb with DNA‐repair proteins is poised to be recruited to sites of DNA‐ADP‐ribosylation (Figure 2b, Model VI), where it mediates removal of the ADPr moiety followed by correction of the associated DNA damage. While we failed to detect DarGMtb bound to DNA, including under conditions that induced ADP‐ribosylation (Figures 2c, S4), it is possible that these interactions are too transient or weak to be detected (Nebbioso et al., 2017). Alternatively, the binding of DarGMtb to DNA may lack sequence specificity, which would preclude detection of enriched peaks at a population level.
Importantly, the DNA‐damage response triggered by activation of DarTMtb leads to increased mutability (Figure 5c), possibly due to the induction of DnaE2, a translesion polymerase implicated in the emergence of drug resistance in vivo (Figure 5b) (Boshoff et al., 2003). Transient hypermutability can promote rapid adaptation to novel environments (Taddei et al., 1997; Jolivet‐Gougeon et al., 2011) and promote the evolution of drug resistance (Blazquez, 2003). Thus, induction of hypermutation by dysregulation of the DarTMtb‐DarGMtb complex could be beneficial to a larger population of Mtb under unfavorable conditions.
Activation of DarTMtb has a bactericidal effect (Figure 3b), similar to induction of MbcT, the toxin of the only other characterized TA system in Mtb harboring an essential antitoxin (Freire et al., 2019). In contrast, most other toxins studied in Mtb exert a bacteriostatic effect (Singh et al., 2010; Tiwari et al., 2015; Agarwal et al., 2018; Sharrock et al., 2018; Tandon et al., 2019). This suggests that, among TA systems, DarGMtb may be an attractive drug target. Indeed, peptides that disrupt the toxin‐antitoxin interface have been designed for other Mtb TA modules and inhibition of antitoxins could be a promising avenue for tuberculosis treatment in general (Williams and Hergenrother, 2012; Chan et al., 2015; Lee et al., 2015; Kang et al., 2017).
4. EXPERIMENTAL PROCEDURES
4.1. Bacterial culture conditions
M. tuberculosis H37Rv and derived strains were cultured in Middlebrook 7H9 medium (BD Difco) containing 0.2% of glycerol, 0.2% of dextrose, 0.5% of BSA (Roche), 0.085% of NaCl, and 0.05% of Tween‐80 or tyloxapol, or in Middlebrook 7H10 agar (BD Difco) containing 10% of OADC supplement (BD) and 0.5% of glycerol. Liquid cultures were incubated under static conditions at 37°C with 5% of CO2. Agar plates were incubated at 37°C. Selection antibiotics were used at the following concentrations: hygromycin (50 μg/ml), kanamycin (25 μg/ml), zeocin (25 μg/ml), and streptomycin (20 μg/ml). ATC was used at 500 ng/ml except where indicated otherwise. For liquid cultures, ATC was replenished 100% every 7 days.
4.2. Generation of strains
All plasmids were generated using Gateway cloning technology (Life Technologies). The ΔdarTMtb‐darGMtb strain was generated from WT M. tuberculosis H37Rv as described in the Results section using recombineering (Gee et al., 2012; Murphy et al., 2015). For the DarGMtb‐pull‐down and ChIP‐seq experiments, WT or ΔdarTMtb‐darGMtb Mtb strains were transformed with an episomal plasmid encoding for darGMtb‐FLAG under the P750 promoter. WT Mtb transformed with an attL5‐integrating vector encoding for FLAG tag alone under the hsp60 promoter served as the negative control for the ChIP‐seq and the pull‐down experiments. WT Mtb transformed with an episomal vector encoding for dosR ‐FLAG under an ATC‐inducible promoter (obtained as a gift from Dr. Tige Rustad, Juno Therapeutics) served as the positive control for the ChIP‐seq. WT Mtb strains transformed with episomal vectors expressing mCherry alone or DarGMtb‐mCherry under the P750 promoter were used for microscopy. The darGMtb‐TetON strain was generated as described in (Johnson et al., 2019). For cross‐complementation studies, the darGMtb‐TetON strain was transformed with episomal plasmids expressing either darGMtb, codon‐adapted darGTaq , or codon‐adapted darGTaqK80A under the hsp60 promoter. Expression of darTTaq was achieved by transforming a giles‐integrating plasmid encoding codon‐adapted darTTaq under an ATC‐inducible promoter (P606) into ΔdarTMtb‐darGMtb Mtb or ΔdarTMtb‐darGMtb Mtb overexpressing DarGMtb‐FLAG.
4.3. Mouse infections
The animal experiments were performed in accordance with National Institutes of Health guidelines for housing and care of laboratory animals and according to institutional regulations after protocol review and approval by the Institutional Animal Care and Use Committee of Weill Cornell Medicine (protocol number 0601441A). Female 7‐ to 8‐week‐old C57BL/6 mice (Jackson Laboratory) were infected with ∼100 CFU using an inhalation exposure system (Glas‐Col). CFU burden of lungs and spleens at each time point was determined by plating dilutions of organ homogenates on 7H10 agar. Four mice were euthanized at each time point for each group.
4.4. Pull‐down of DarGMtb
About 150 ml of mid‐log phase Mtb culture was washed with PBS containing 0.05% of Tween 80 (PBST), resuspended in lysis buffer + protease inhibitors, lysed with 0.1 mm zirconia beads and incubated with anti‐Flag beads. We washed the beads three times with PBS before elution with FLAG peptides. The eluates were analyzed by mass spectrometry. For the DNaseI treatment, anti‐Flag beads were incubated with Mtb whole‐cell lysates overnight, washed five times with PBS, and then, treated with 25 units of DNaseI at 37°C under gentle shaking for 3 hr.
4.5. Microscopy
Mtb cultures were collected by centrifugation, washed with PBS containing 0.05% of Tween 80 (PBST), fixed with 4% of paraformaldehyde overnight prior to removal from BSL‐3 containment and incubated with 5 μM SYTO 13 (Thermo Fisher Scientific) for 5 min for nucleoid labeling. Single cell suspensions were prepared by centrifugation at 800 rpm for 10 min. After spreading on soft agar pads, bacteria were visualized with a DeltaVision image restoration microscope (GE Healthcare), a 100x oil objective and appropriate filter sets. Images were captured with a pco.edge scientific SCOS camera and analyzed with ImageJ (Schneider et al., 2012).
4.6. ChIP‐seq of DarGMtb
About 50 ml cultures of Mtb overexpressing FLAG‐tagged proteins were grown to an OD of 0.8–1.2. For cultures expressing DosR‐FLAG, expression was induced by addition of ATC (100 ng/ml) for 4 days before addition of formaldehyde. For cultures expressing DarTTaq , expression was induced by adding ATC (500 ng/ml) for 8 days before addition of formaldehyde. Chromatin immunoprecipitation was performed as in (Minch et al., 2015). NGS library preparation was performed using NEBNext Ultra II DNA Library prep kit for Illumina. Samples were sequenced using standard Illumina protocols producing ~40 million 50‐bp single‐end reads. Reads were aligned to the reference genome using Bowtie 2.3 (Langmead and Salzberg, 2012). BAM alignment files were created, sorted and indexed using SAMtools (Li et al., 2009) and viewed in the IGV viewer (Robinson et al., 2011). Peak calling was performed using MACS2 (Zhang et al., 2008). Computation of differentially bound sites was performed using DiffBind (Stark and Brown, 2011). For ChIP of DarGMtb under baseline conditions, peaks from DarGMtb‐FLAG were compared against the FLAG control. For ChIP of DarGMtb from cells overexpressing DarTTaq, peaks from the +ATC condition were compared against the ‐ATC condition as control.
4.7. Western Blots
Rabbit polyclonal antibody for DarGMtb was generated by GenScript. DlaT antibody (Bryk et al., 2002) was a gift from R. Bryk and C. Nathan at Weill Cornell Medicine. All secondary antibodies were purchased from LI‐COR biosciences. Protein lysates were prepared by mechanical lysis with 0.1 mm zirconia beads. Unbroken bacterial cells and beads were removed by centrifugation and supernatants were filtered using 0.22 μm spin‐X columns prior to removal from BSL‐3 containment. Protein lysates were separated using SDS‐PAGE and transferred to a nitrocellulose membrane. After washing and incubation with secondary antibodies, proteins were visualized using Odyssey Infrared Imaging System (LI‐COR Biosciences).
4.8. d arG Mtb‐tetON antibiotic susceptibility
darGMtb‐tetON cultures were grown to till mid‐log phase in 7H9 medium + ATC and washed twice in 7H9 medium ‐ATC. Washed cultures were diluted to an OD of 0.02 and grown for 6 days in 7H9 medium ‐ATC to pre‐deplete DarGMtb. Pre‐depleted cultures were used to inoculate 384‐well black plates with clear flat bottoms that contained a range of ATC/drug concentrations at an OD of 0.01. Drugs were dispensed using an HP D300e Digital Dispenser (Hewlett Packard). The drug dispensing was randomized using the HP Digital Dispenser software (version 3.2.2), and the dimethyl sulfoxide (DMSO) concentration in each well was normalized to 1%–2%. After incubation for 14 days, the optical density (OD580) in each well was read using a SoftMax M2 plate reader. The data were de‐randomized using HP Digital Dispenser Data Merge software.
4.9. d arG Mtb‐tetON Tn‐seq
darGMtb‐tetON cultures were grown to mid‐log phase in 7H9 medium + ATC and washed twice in 7H9 medium ‐ATC. Washed cultures were diluted to an OD of 0.25 and grown for 3 days in 7H9 medium ‐ATC to pre‐deplete DarGMtb. Pre‐depleted cultures were transduced with ΦMycoMarT7 phage as previously described (Long et al., 2015; Xu et al., 2017) and plated on 7H10 agar plates with 0.05% of tyloxapol and ATC at two different concentrations: 15 ng/ml ATC (ATC‐low) and 500 ng/ml (ATC‐high). Plates were incubated for 21 days before harvesting, extracting genomic DNA and sequencing as described previously (Long et al., 2015; Xu et al., 2017). Mapping and quantification of transposon insertions was done as described previously (Xu et al., 2017). Differentially represented genes were identified using resampling in the TRANSIT analysis platform as described previously (DeJesus et al., 2015; Xu et al., 2017). We defined genes having a q‐value of ≤.05 and a log2FC ≥ 1 or log2FC ≤ −1 as significant.
4.10. d arG Mtb‐tetON RNA‐seq
darGMtb‐tetON cultures were grown to mid‐log phase in 7H9 medium + ATC and washed twice in PBS‐tyloxapol 0.05%. Washed cultures were diluted to an OD of 0.015 and grown for 7 days in 7H9 medium ‐ATC (low ATC) or + ATC (high ATC). Total RNA was extracted as described in (Botella et al., 2017) and Illumina cDNA libraries were generated using the RNAtag‐Seq protocol as described in (Shishkin et al., 2015) and (Botella et al., 2017) and sequenced on HiSeq 4000 to generate 50 bases paired‐end reads. The samples from three independent replicates were processed in two rounds of library preparation and sequencing.
The sequencing reads were cleaned by trimming adapter sequences and low quality bases using cutadapt v1.9.1 (Martin, 2011), and were aligned to a modified M. tuberculosis reference genome using BWA v0.7.15 (Li and Durbin, 2009). The original M. tuberculosis genome (H37Rv) was retrieved from NCBI (https://www.ncbi.nlm.nih.gov/nuccore/NC_000962.3) and modified to add a 1,303 bp insertion before the stop codon of the gene darGMtb. Raw read counts per gene were extracted using HTSeq‐count v 0.6.1 (Anders et al., 2015). Differential expression analysis was performed using the Agilent GeneSpring software.
4.11. Measuring mutability of darG Mtb‐tetON
darGMtb‐tetON cultures were grown till mid‐log phase in 7H9 medium + ATC and washed twice in 7H9 medium −ATC. Washed cultures were diluted to an OD of 0.05 and grown for 18 days in 7H9 medium with or without ATC. Cells were pelleted and plated on 7H10 agar plates with no rifampicin or 1 μg/ml rifampicin. Colonies were counted after ~3–4 weeks of incubation.
AUTHOR CONTRIBUTIONS
All authors contributed to the conception and design of the study. AZ, RW, LB, RS, LZ, JBW, NS, and RSJ contributed to the acquisition and analysis of data. AZ, SE, DS, and RW contributed to the writing of the manuscript. The authors declare no conflict of interest.
Supporting information
Fig S1‐4
Table S1
Table S2
Table S3
ACKNOWLEDGMENTS
We thank T. Yu and J.A. McConnell for assistance with experiments. We thank T. Rustad (Juno Therapeutics) for advice regarding ChIP‐seq and for providing the DosR overexpression plasmid. We thank K.G. Papavinasasundaram (University of Massachusetts) and S.A. Shaffer (University of Massachusetts, Mass Spectrometry Facility) for LC‐MS/MS analysis. We thank T. Zhang (Genomics Resources Core Facility, Weill Cornell Medicine) for analysis of the RNA‐seq data. We thank T. Ioerger for advice regarding transposon sequencing. We thank R. Bryk and C. Nathan (Weill Cornell Medicine) for the DlaT antibody.
Zaveri A, Wang R, Botella L, et al. Depletion of the DarG antitoxin in Mycobacterium tuberculosis triggers the DNA-damage response and leads to cell death. Mol Microbiol. 2020;114:641–652. 10.1111/mmi.14571
Funding information
This work was supported by the Tri‐Institutional TB Research Unit (NIH grant U19 AI111143) and NIH grant U19 A107774.
DATA AVAILABILITY STATEMENT
Data that support the findings of this study can be found in the Supporting Information of this article. Raw data from the Tn‐seq and RNA‐seq experiments are deposited under BioProject accession number PRJNA640933 in the NCBI BioProject database (https://www.ncbi.nlm.nih.gov/bioproject/).
REFERENCES
- Agarwal, S. , Tiwari, P. , Deep, A. , Kidwai, S. , Gupta, S. , Thakur, K. G. , et al (2018) System‐wide analysis unravels the differential regulation and in vivo essentiality of virulence‐associated proteins B and C toxin‐antitoxin systems of Mycobacterium tuberculosis . Journal of Infectious Diseases, 217, 1809–1820. 10.1093/infdis/jiy109. [DOI] [PubMed] [Google Scholar]
- Anders, S. , Pyl, P. T. and Huber, W. (2015) HTSeq–a Python framework to work with high‐throughput sequencing data. Bioinformatics, 31, 166–169. 10.1093/bioinformatics/btu638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boshoff, H. I. , Reed, M. B. , Barry, C. E. 3rd and Mizrahi, V. (2003) DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis . Cell, 113, 183–193. 10.1016/S0092-8674(03)00270-8. [DOI] [PubMed] [Google Scholar]
- Botella, L. , Vaubourgeix, J. , Livny, J. and Schnappinger, D. (2017) Depleting Mycobacterium tuberculosis of the transcription termination factor Rho causes pervasive transcription and rapid death. Nature Communications, 8, 14731 10.1038/ncomms14731. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bryk, R. , Lima, C. D. , Erdjument‐Bromage, H. , Tempst, P. and Nathan, C. (2002) Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin‐like protein. Science, 295, 1073–1077. 10.1126/science.1067798. [DOI] [PubMed] [Google Scholar]
- Chan, W. T. , Balsa, D. and Espinosa, M. (2015) One cannot rule them all: are bacterial toxins‐antitoxins druggable? FEMS Microbiology Reviews, 39, 522–540. 10.1093/femsre/fuv002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DeJesus, M. A. , Ambadipudi, C. , Baker, R. , Sassetti, C. and Ioerger, T. R. (2015) TRANSIT–A software tool for Himar1 TnSeq analysis. PLoS Computational Biology, 11, e1004401 10.1371/journal.pcbi.1004401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DeJesus, M. A. , Gerrick, E. R. , Xu, W. , Park, S. W. , Long, J. E. , Boutte, C. C. , et al (2017) Comprehensive essentiality analysis of the Mycobacterium tuberculosis Genome via saturating transposon Mutagenesis. mBio, 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dubnau, E. , Chan, J. , Raynaud, C. , Mohan, V. P. , Laneelle, M. A. , Yu, K. , et al (2000) Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Molecular Microbiology, 36, 630–637. 10.1046/j.1365-2958.2000.01882.x. [DOI] [PubMed] [Google Scholar]
- Eliopoulos, G. M. and Blazquez, J. (2003) Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clinical Infectious Diseases, 37, 1201–1209. 10.1086/378810. [DOI] [PubMed] [Google Scholar]
- Freire, D. M. , Gutierrez, C. , Garza‐Garcia, A. , Grabowska, A. D. , Sala, A. J. , Ariyachaokun, K. , et al (2019) An NAD(+) phosphorylase toxin triggers Mycobacterium tuberculosis cell death. Molecular Cell, 73(1282–1291), e1288 10.1016/j.molcel.2019.01.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fudrini Olivencia, B. , Muller, A. U. , Roschitzki, B. , Burger, S. , Weber‐Ban, E. and Imkamp, F. (2017) Mycobacterium smegmatis PafBC is involved in regulation of DNA damage response. Scientific Reports, 7, 13987 10.1038/s41598-017-14410-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gee, C. L. , Papavinasasundaram, K. G. , Blair, S. R. , Baer, C. E. , Falick, A. M. , King, D. S. , et al (2012) A phosphorylated pseudokinase complex controls cell wall synthesis in mycobacteria. Science Signalling, 5, ra7 10.1126/scisignal.2002525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gerdes, K. and Maisonneuve, E. (2012) Bacterial persistence and toxin‐antitoxin loci. Annual Review of Microbiology, 66, 103–123. 10.1146/annurev-micro-092611-150159. [DOI] [PubMed] [Google Scholar]
- Gerdes, K. , Rasmussen, P. B. and Molin, S. (1986) Unique type of plasmid maintenance function: Postsegregational killing of plasmid‐free cells. Proceedings of the National Academy of Sciences, 83, 3116–3120. 10.1073/pnas.83.10.3116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harms, A. , Brodersen, D. E. , Mitarai, N. and Gerdes, K. (2018) Toxins, targets, and triggers: an overview of toxin‐antitoxin biology. Molecular Cell, 70, 768–784. 10.1016/j.molcel.2018.01.003. [DOI] [PubMed] [Google Scholar]
- Iyer, V. N. and Szybalski, W. (1963) A molecular mechanism of mitomycin action: linking of complementary DNA strands. Proceedings of the National Academy of Sciences, 50, 355–362. 10.1073/pnas.50.2.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jankevicius, G. , Ariza, A. , Ahel, M. and Ahel, I. (2016) The toxin‐antitoxin system DarTG catalyzes reversible ADP‐ribosylation of DNA. Molecular Cell, 64, 1109–1116. 10.1016/j.molcel.2016.11.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johnson, E. O. , LaVerriere, E. , Office, E. , Stanley, M. , Meyer, E. , Kawate, T. , et al (2019) Large‐scale chemical‐genetics yields new M. tuberculosis inhibitor classes. Nature, 571, 72–78. 10.1038/s41586-019-1315-z. [DOI] [PubMed] [Google Scholar]
- Jolivet‐Gougeon, A. , Kovacs, B. , Le Gall‐David, S. , Le Bars, H. , Bousarghin, L. , Bonnaure‐Mallet, M. , et al (2011) Bacterial hypermutation: Clinical implications. Journal of Medical Microbiology, 60, 563–573. 10.1099/jmm.0.024083-0. [DOI] [PubMed] [Google Scholar]
- Kanehisa, M. and Goto, S. (2000) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Research, 28, 27–30. 10.1093/nar/28.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kang, S. M. , Kim, D. H. , Lee, K. Y. , Park, S. J. , Yoon, H. J. , Lee, S. J. , et al (2017) Functional details of the Mycobacterium tuberculosis VapBC26 toxin‐antitoxin system based on a structural study: Insights into unique binding and antibiotic peptides. Nucleic Acids Research, 45, 8564–8580. 10.1093/nar/gkx489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim, J. H. , Wei, J. R. , Wallach, J. B. , Robbins, R. S. , Rubin, E. J. and Schnappinger, D. (2011) Protein inactivation in mycobacteria by controlled proteolysis and its application to deplete the beta subunit of RNA polymerase. Nucleic Acids Research, 39, 2210–2220. 10.1093/nar/gkq1149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Langmead, B. and Salzberg, S. L. (2012) Fast gapped‐read alignment with Bowtie 2. Nature Methods, 9, 357–359. 10.1038/nmeth.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lawaree, E. , Jankevicius, G. , Cooper, C. , Ahel, I. , Uphoff, S. and Tang, C. M. (2020) DNA ADP‐ribosylation stalls replication and is reversed by RecF‐mediated homologous recombination and nucleotide excision repair. Cell Reports, 30(1373–1384), e1374 10.1016/j.celrep.2020.01.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee, I. G. , Lee, S. J. , Chae, S. , Lee, K. Y. , Kim, J. H. and Lee, B. J. (2015) Structural and functional studies of the Mycobacterium tuberculosis VapBC30 toxin‐antitoxin system: implications for the design of novel antimicrobial peptides. Nucleic Acids Research, 43, 7624–7637. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li, H. and Durbin, R. (2009) Fast and accurate short read alignment with Burrows‐Wheeler transform. Bioinformatics, 25, 1754–1760. 10.1093/bioinformatics/btp324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li, H. , Handsaker, B. , Wysoker, A. , Fennell, T. , Ruan, J. , Homer, N. , et al (2009) The sequence alignment/map format and SAMtools. Bioinformatics, 25(16), 2078–2079. 10.1093/bioinformatics/btp352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Long, J. E. , DeJesus, M. , Ward, D. , Baker, R. E. , Ioerger, T. and Sassetti, C. M. (2015) Identifying essential genes in Mycobacterium tuberculosis by global phenotypic profiling. Methods in Molecular Biology, 1279, 79–95. [DOI] [PubMed] [Google Scholar]
- Martin, M. (2011) Cutadapt removes adapter sequences from high‐throughput sequencing reads. EMBnet Journal, 2011(17), 3 10.14806/ej.17.1.200. [DOI] [Google Scholar]
- Minch, K. J. , Rustad, T. R. , Peterson, E. J. , Winkler, J. , Reiss, D. J. , Ma, S. , et al (2015) The DNA‐binding network of Mycobacterium tuberculosis . Nature Communications, 6, 5829 10.1038/ncomms6829. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Muller, A. U. , Imkamp, F. and Weber‐Ban, E. (2018) The Mycobacterial LexA/RecA‐independent DNA damage response is controlled by PafBC and the Pup‐proteasome system. Cell Reports, 23, 3551–3564. 10.1016/j.celrep.2018.05.073. [DOI] [PubMed] [Google Scholar]
- Murphy, K. C. , Papavinasasundaram, K. and Sassetti, C. M. (2015) Mycobacterial recombineering. Methods in Molecular Biology, 1285, 177–199. [DOI] [PubMed] [Google Scholar]
- Nebbioso, A. , Benedetti, R. , Conte, M. , Carafa, V. , De Bellis, F. , Shaik, J. , et al (2017) Time‐resolved analysis of DNA‐protein interactions in living cells by UV laser pulses. Scientific Reports, 7, 11725 10.1038/s41598-017-12010-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ogura, T. and Hiraga, S. (1983) Mini‐F plasmid genes that couple host cell division to plasmid proliferation. Proceedings of the National Academy of Sciences, 80, 4784–4788. 10.1073/pnas.80.15.4784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pandey, D. P. and Gerdes, K. (2005) Toxin‐antitoxin loci are highly abundant in free‐living but lost from host‐associated prokaryotes. Nucleic Acids Research, 33, 966–976. 10.1093/nar/gki201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pashley, C. A. and Parish, T. (2003) Efficient switching of mycobacteriophage L5‐based integrating plasmids in Mycobacterium tuberculosis. FEMS Microbiology Letters, 229, 211–215. [DOI] [PubMed] [Google Scholar]
- Ramage, H. R. , Connolly, L. E. and Cox, J. S. (2009) Comprehensive functional analysis of Mycobacterium tuberculosis toxin‐antitoxin systems: implications for pathogenesis, stress responses, and evolution. PLoS Genetics, 5, e1000767 10.1371/journal.pgen.1000767. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robinson, J. T. , Thorvaldsdottir, H. , Winckler, W. , Guttman, M. , Lander, E. S. , Getz, G. et al (2011) Integrative genomics viewer. Nature Biotechnology, 29, 24–26. 10.1038/nbt.1754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sala, A. , Bordes, P. and Genevaux, P. (2014) Multiple toxin‐antitoxin systems in Mycobacterium tuberculosis . Toxins (Basel), 6, 1002–1020. 10.3390/toxins6031002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schneider, C. A. , Rasband, W. S. and Eliceiri, K. W. (2012) NIH Image to ImageJ: 25 years of image analysis. Nature Methods, 9, 671–675. 10.1038/nmeth.2089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sharrock, A. , Ruthe, A. , Andrews, E. S. V. , Arcus, V. A. and Hicks, J. L. (2018) VapC proteins from Mycobacterium tuberculosis share ribonuclease sequence specificity but differ in regulation and toxicity. PLoS One, 13, e0203412 10.1371/journal.pone.0203412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shishkin, A. A. , Giannoukos, G. , Kucukural, A. , Ciulla, D. , Busby, M. , Surka, C. , et al (2015) Simultaneous generation of many RNA‐seq libraries in a single reaction. Nature Methods, 12, 323–325. 10.1038/nmeth.3313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Singh, A. (2017) Guardians of the mycobacterial genome: a review on DNA repair systems in Mycobacterium tuberculosis. Microbiology, 163, 1740–1758. 10.1099/mic.0.000578. [DOI] [PubMed] [Google Scholar]
- Singh, R. , Barry, C. E., 3rd and Boshoff, H. I. (2010) The three RelE homologs of Mycobacterium tuberculosis have individual, drug‐specific effects on bacterial antibiotic tolerance. Journal of Bacteriology, 192, 1279–1291. 10.1128/JB.01285-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Slayden, R. A. , Dawson, C. C. and Cummings, J. E. (2018) Toxin–antitoxin systems and regulatory mechanisms in Mycobacterium tuberculosis . Pathogens and Disease, 76(4), 10.1093/femspd/fty039. [DOI] [PubMed] [Google Scholar]
- Stark, R. and Brown, G. (2011) DiffBind: differential binding analysis of ChIP‐Seq peak data. R Package Version, 100,3–4. [Google Scholar]
- Szekeres, S. , Dauti, M. , Wilde, C. , Mazel, D. and Rowe‐Magnus, D. A. (2007) Chromosomal toxin‐antitoxin loci can diminish large‐scale genome reductions in the absence of selection. Molecular Microbiology, 63, 1588–1605. 10.1111/j.1365-2958.2007.05613.x. [DOI] [PubMed] [Google Scholar]
- Taddei, F. , Radman, M. , Maynard‐Smith, J. , Toupance, B. , Gouyon, P. H. and Godelle, B. (1997) Role of mutator alleles in adaptive evolution. Nature, 387, 700–702. 10.1038/42696. [DOI] [PubMed] [Google Scholar]
- Tandon, H. , Sharma, A. , Sandhya, S. , Srinivasan, N. and Singh, R. (2019) Mycobacterium tuberculosis Rv0366c‐Rv0367c encodes a non‐canonical PezAT‐like toxin‐antitoxin pair. Scientific Reports, 9, 1163 10.1038/s41598-018-37473-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tiwari, P. , Arora, G. , Singh, M. , Kidwai, S. , Narayan, O. P. and Singh, R. (2015) MazF ribonucleases promote Mycobacterium tuberculosis drug tolerance and virulence in guinea pigs. Nature Communications, 6, 6059 10.1038/ncomms7059. [DOI] [PubMed] [Google Scholar]
- Williams, J. J. and Hergenrother, P. J. (2012) Artificial activation of toxin‐antitoxin systems as an antibacterial strategy. Trends in Microbiology, 20, 291–298. 10.1016/j.tim.2012.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xu, W. , DeJesus, M. A. , Rucker, N. , Engelhart, C. A. , Wright, M. G. , Healy, C. , et al (2017) Chemical genetic interaction profiling reveals determinants of intrinsic antibiotic resistance in Mycobacterium tuberculosis . Antimicrobial Agents and Chemotherapy, 61 10.1128/AAC.01334-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yamaguchi, Y. , Park, J. H. and Inouye, M. (2011) Toxin‐antitoxin systems in bacteria and archaea. Annual Review of Genetics, 45, 61–79. 10.1146/annurev-genet-110410-132412. [DOI] [PubMed] [Google Scholar]
- Yuan, Y. and Barry, C. E., 3rd (1996) A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis . Proceedings of the National Academy of Sciences, 93, 12828–12833. 10.1073/pnas.93.23.12828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang, Y. , Liu, T. , Meyer, C. A. , Eeckhoute, J. , Johnson, D. S. , Bernstein, B. E. , et al (2008) Model‐based analysis of ChIP‐Seq (MACS). Genome Biology, 9, R137 10.1186/gb-2008-9-9-r137. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Fig S1‐4
Table S1
Table S2
Table S3
Data Availability Statement
Data that support the findings of this study can be found in the Supporting Information of this article. Raw data from the Tn‐seq and RNA‐seq experiments are deposited under BioProject accession number PRJNA640933 in the NCBI BioProject database (https://www.ncbi.nlm.nih.gov/bioproject/).
